Join to View Full Profile
9000 Rockville PikeBldg 10Bethesda, MD 20892
Phone+1 301-496-4000
Dr. Lisco is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Andrea Lisco is an infectious disease specialist in Bethesda, MD and is affiliated with NIH Clinical Center. He received his medical degree from University of Bari Faculty of Medicine and has been in practice 17 years. He specializes in Hiv/Aids medicine and clinical immunology. He has more than 90 publications and over 2000 citations.
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2014 - 2016
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2011 - 2014
University of Bari Faculty of MedicineClass of 2000
Certifications & Licensure
DC State Medical License 2014 - 2027
OH State Medical License 2011 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia Start of enrollment: 2019 Feb 04
- A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia Start of enrollment: 2024 Nov 06
- Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune) Start of enrollment: 2021 Nov 17
Publications & Presentations
PubMed
- Impact of Anti-CD4 Autoantibodies on Immune Reconstitution in People With Advanced Human Immunodeficiency Virus.Brian P Epling, Andrea Lisco, Maura Manion, Elizabeth Laidlaw, Frances Galindo
Clinical Infectious Diseases. 2024-12-18 - 1 citationsHigh Rates of High-risk HPV Anal Infection and Abnormal Cytology in a Cohort of Transgender People Assigned Male at Birth.Omar Harfouch, Andrea Lisco, Habib Omari, Rahwa Eyasu, Ashley Davis
Open Forum Infectious Diseases. 2024-12-01 - Safety but limited efficacy of donor lymphocyte infusion for post-transplantation cyclophosphamide-treated patients.Krithika Shanmugasundaram, Scott Napier, Dimana Dimitrova, Anita Stokes, Jennifer Wilder
Bone Marrow Transplantation. 2024-11-01
Press Mentions
NIH Researchers Uncover New Details on Rare Immune DiseaseMay 3rd, 2023
Study Identifies Rare Cases of Immune System Failure in Virally Suppressed HIV PatientsApril 29th, 2019
In Rare Cases, Immune System Fails Despite HIV SuppressionApril 19th, 2019
Grant Support
- Identification of immunological predictors of COVID-19 clinical outcomesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Immunopathogenesis of skin and mucosal Human Papillomavirus (HPV)-related diseasesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Identification of immunological predictors of COVID-19 clinical outcomesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Immunopathogenesis of skin and mucosal Human Papillomavirus (HPV)-related diseasesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Identification of immunological predictors of COVID-19 clinical outcomesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Immunopathogenesis of skin and mucosal Human Papillomavirus (HPV)-related diseasesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Immunopathogenesis of skin and mucosal Human Papillomavirus (HPV)-related diseasesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Immunopathogenesis of skin and mucosal Human Papillomavirus (HPV)-related diseasesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Identification of immunological predictors of COVID-19 clinical outcomesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Identification of immunological predictors of COVID-19 clinical outcomesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
